Neoplasie della mammella
Anno: 1997
-
Riferimento:J Pineal Res. 1997 May;22(4):184-202. Review.Azione della melatonina:Melatonin could indeed be considered a physiological anticancer substance.Target:Antioxidative functions, indirect immunostimulatory effects.
-
Riferimento:Support Care Cancer. 1997 Mar;5(2):126-9.Azione della melatonina:Concomitant administration of MLT during chemo-therapy may prevent some chemotherapy-induced side-effects,Target:Influence of MLT on chemotherapy toxicity.
-
Riferimento:Bioelectromagnetics. 1997;18(8):555-62.Azione della melatonina:Melatonin (10(-9) M) and tamoxifen (10(-7) M) may act through different biological pathways to down-regulate cell growth.Target:EMF (1.2 microT, 60 Hz).
-
Riferimento:Breast Cancer Res Treat. 1997 Jan;42(1):15-22.Azione della melatonina:Breast cancer women had a reversal of the normal seasonal pattern of melatonin secretion.Target:Seasonal variation.
Anno: 1998
-
Riferimento:Lancet. 1998 Aug 22;352(9128):626.Azione della melatonina:No abstract available.Target:No abstract available.
-
Titolo: Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factorsRiferimento:Mol Cell Endocrinol. 1998 Jun 25;141(1-2):53-64.Azione della melatonina:Melatonin and EGF transactivate the ER, making the ER refractory to activation by estradiol.Target:Estrogen receptor (ER), epidermal growth factor (EGF).
-
Riferimento:Menopause. 1998 Spring;5(1):60-4. Review.Azione della melatonina:Melatonin might be implicated in menopause-associated processes such as breast cancer.Target:Melatonin replacement therapy.
-
Riferimento:Int J Biol Markers. 1998 Jul-Sep;13(3):154-7.Azione della melatonina:Studies evaluating circadian DHEAS secretion in relation in that of the pineal hormone MLT.Target:Dehydroepiandrosteronesulfate (DHEAS).
-
Riferimento:Br J Cancer. 1998 Jun;77(12):2129-37.Azione della melatonina:Melatonin (10(-9) M)and atRA (10(-9) M) should be considered for preclinical and clinical evaluation against ER-positive human breast cancer.Target:Oestrogen receptor (ER), all-trans retinoic acid (atRA).
-
Riferimento:Mol Carcinog. 1998 Mar;21(3):149-55. Review.Azione della melatonina:Reduction of melatonin levels by EMFs can caused inactivation of melatonin receptors which may cause cancer.Target:Electromagnetic fields (EMFs).